October 2, 2018

https://www.prnewswire.com/news-releases/fda-grants-profounda-inc-competitive-generic-therapy-cgt-designation-for-planned-anda-filing-of-minocycline-hydrochloride-microspheres1-mg-300719797.html

December 31, 2016

Orphan indication received by Profounda is for the treatment of Acanthamoeba Keratitis, also commonly known as AK usually associated with contact lens wear.

ORLANDO, Fla. 

Please reload

Featured Posts

http://www.clickorlando.com/news/broward-teen-survives-brain-eating-amoeba-was-treated-in-orlando

Patient survives Brain Eating Amoeba

September 12, 2016

1/3
Please reload

Recent Posts
Please reload

Archive
Please reload

Search By Tags
Please reload

© Profounda Pharmaceuticals